| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
60,743,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.92 - $2.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Glenn John |
Chief Financial Officer |
• – – |
2012-02-09 |
4 |
D |
$2.99 |
$32,845 |
D/D |
(10,985) |
208,717 |
|
- |
|
| Glenn John |
Chief Financial Officer |
• – – |
2012-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,684 |
219,702 |
|
- |
|
| Yorkey Thomas J. |
Vice President, Research & Dev |
• – – |
2012-02-09 |
4 |
D |
$2.99 |
$10,964 |
D/D |
(3,667) |
90,500 |
|
- |
|
| Yorkey Thomas J. |
Vice President, Research & Dev |
• – – |
2012-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,752 |
94,167 |
|
- |
|
| Fanning Stephen J |
President & CEO |
• • – |
2012-02-09 |
4 |
D |
$2.99 |
$80,494 |
D/D |
(26,921) |
493,835 |
|
- |
|
| Fanning Stephen J |
President & CEO |
• • – |
2012-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
73,392 |
520,756 |
|
- |
|
| Foss Kristine A |
VP,Regulatory,Clinical,Quality |
• – – |
2012-02-09 |
4 |
D |
$2.99 |
$20,942 |
D/D |
(7,004) |
108,711 |
|
- |
|
| Foss Kristine A |
VP,Regulatory,Clinical,Quality |
• – – |
2012-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,832 |
115,715 |
|
- |
|
| Nardoci Jeffrey C |
Vice President of Marketing |
• – – |
2012-02-09 |
4 |
D |
$2.99 |
$21,429 |
D/D |
(7,167) |
115,250 |
|
- |
|
| Nardoci Jeffrey C |
Vice President of Marketing |
• – – |
2012-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,304 |
122,417 |
|
- |
|
| Heigel Douglas W |
VP Operations |
• – – |
2012-02-09 |
4 |
D |
$2.99 |
$24,261 |
D/D |
(8,114) |
190,792 |
|
- |
|
| Heigel Douglas W |
VP Operations |
• – – |
2012-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,132 |
198,906 |
|
- |
|
| Brodie William |
Vice President of Global Sales |
• – – |
2012-02-09 |
4 |
D |
$2.99 |
$28,569 |
D/D |
(9,555) |
159,749 |
|
- |
|
| Brodie William |
Vice President of Global Sales |
• – – |
2012-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,240 |
169,304 |
|
- |
|
| Ferrari H Daniel |
Vice President of Finance |
• – – |
2012-02-09 |
4 |
D |
$2.99 |
$22,796 |
D/D |
(7,624) |
139,403 |
|
- |
|
| Ferrari H Daniel |
Vice President of Finance |
• – – |
2012-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,347 |
147,027 |
|
- |
|
| Yorkey Thomas J. |
Vice President, Research & Dev |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
63,000 |
89,000 |
|
- |
|
| Foss Kristine A |
VP,Regulatory,Clinical,Quality |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
105,000 |
|
- |
|
| Brodie William |
Vice President of Global Sales |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
73,250 |
153,870 |
|
- |
|
| Heigel Douglas W |
VP Operations |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
54,250 |
186,088 |
|
- |
|
| Glenn John |
Chief Financial Officer |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
93,000 |
201,436 |
|
- |
|
| Nardoci Jeffrey C |
Vice President of Marketing |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
111,400 |
|
- |
|
| Ferrari H Daniel |
Vice President of Finance |
• – – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
56,000 |
135,347 |
|
- |
|
| Fanning Stephen J |
Chairman, President & CEO |
• • – |
2012-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
207,750 |
474,020 |
|
- |
|
| Brodie William |
Vice President of Global Sales |
• – – |
2011-11-10 |
4 |
S |
$2.21 |
$44,200 |
D/D |
(20,000) |
80,620 |
|
- |
|
321 Records found
|
|
Page 5 of 13 |
|
|
